Yu‐Ping He

666 total citations
31 papers, 553 citations indexed

About

Yu‐Ping He is a scholar working on Complementary and alternative medicine, Physiology and Molecular Biology. According to data from OpenAlex, Yu‐Ping He has authored 31 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Complementary and alternative medicine, 9 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Yu‐Ping He's work include Alzheimer's disease research and treatments (9 papers), Medicinal Plants and Neuroprotection (8 papers) and Autophagy in Disease and Therapy (6 papers). Yu‐Ping He is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Medicinal Plants and Neuroprotection (8 papers) and Autophagy in Disease and Therapy (6 papers). Yu‐Ping He collaborates with scholars based in China and Nepal. Yu‐Ping He's co-authors include Yongqi Fang, Sheng Zhang, Liping Huang, Zhentao Mo, Minzhen Deng, Wei Yang, Hua Wu, Wenpeng Huang, Ling Li and Lin Liu and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Yu‐Ping He

30 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ping He China 15 153 151 148 138 119 31 553
Longjian Huang China 13 250 1.6× 64 0.4× 91 0.6× 91 0.7× 175 1.5× 29 652
Neeraj Tiwari India 11 181 1.2× 75 0.5× 87 0.6× 57 0.4× 62 0.5× 23 570
Baojian Guo China 16 260 1.7× 120 0.8× 86 0.6× 43 0.3× 106 0.9× 26 674
Zhipeng Teng China 12 260 1.7× 47 0.3× 164 1.1× 129 0.9× 83 0.7× 19 755
Yihui Deng China 12 317 2.1× 86 0.6× 80 0.5× 105 0.8× 316 2.7× 33 754
Xiaowei Lu China 15 364 2.4× 63 0.4× 101 0.7× 61 0.4× 69 0.6× 39 916

Countries citing papers authored by Yu‐Ping He

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ping He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ping He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ping He more than expected).

Fields of papers citing papers by Yu‐Ping He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ping He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ping He. The network helps show where Yu‐Ping He may publish in the future.

Co-authorship network of co-authors of Yu‐Ping He

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ping He. A scholar is included among the top collaborators of Yu‐Ping He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ping He. Yu‐Ping He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yu‐Ping, et al.. (2025). Switchable skeletal editing of quinolines enabled by cyclizative sequential rearrangements. Nature Chemistry. 17(6). 952–960. 9 indexed citations
2.
Li, Yanping, Jingyi Tang, Yuxi Zhang, et al.. (2024). Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer. International Immunopharmacology. 133. 112157–112157. 8 indexed citations
3.
He, Yu‐Ping, Minghao Xu, Chenhao Zhou, et al.. (2024). The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma. International Journal of General Medicine. Volume 17. 4867–4881. 3 indexed citations
4.
Zhang, Yuhe, et al.. (2023). Effect of gastrodin against cognitive impairment and neurodegeneration in APP/PS1 mice via regulating gut microbiota–gut–brain axis. Experimental Brain Research. 241(6). 1661–1673. 11 indexed citations
5.
Sun, Ting, et al.. (2022). Curcumin Enhanced Ionizing Radiation‐Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2022(1). 5424411–5424411. 23 indexed citations
6.
Sun, Ting, Yanyan Li, Ying Yang, et al.. (2022). Downregulation of exosomal MHC-I promotes glioma cells escaping from systemic immunosurveillance. Nanomedicine Nanotechnology Biology and Medicine. 46. 102605–102605. 13 indexed citations
7.
Yang, Wei, et al.. (2020). Bip inhibition in glioma stem cells promotes radiation-induced immunogenic cell death. Cell Death and Disease. 11(9). 786–786. 24 indexed citations
8.
He, Yu‐Ping, et al.. (2016). Prevalence of symptomatic dry eye disease among Chinese college students with associated risk factors. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Zhang, Sheng, et al.. (2014). Beta-asarone attenuates amyloid beta-induced autophagy via Akt/mTOR pathway in PC12 cells. European Journal of Pharmacology. 741. 195–204. 57 indexed citations
11.
Zhang, Sheng, Liping Huang, Minzhen Deng, et al.. (2014). Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway. Molecular Neurobiology. 53(1). 83–94. 61 indexed citations
12.
He, Yu‐Ping, et al.. (2013). Establish a flow cytometric method for quantitative detection of Beclin-1 expression. Cytotechnology. 65(4). 481–489. 16 indexed citations
13.
Zhang, Sheng, et al.. (2013). Dynamic Expressions of Beclin 1 and Tyrosine Hydroxylase in Different Areas of 6-Hydroxydopamine-Induced Parkinsonian Rats. Cellular and Molecular Neurobiology. 33(7). 973–981. 18 indexed citations
14.
Mo, Zhentao, Yongqi Fang, Yu‐Ping He, & Sheng Zhang. (2012). β-Asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy. Acta Pharmacologica Sinica. 33(6). 737–742. 64 indexed citations
15.
Mo, Zhentao, et al.. (2012). Change of Beclin‐1 dependent on ATP, [Ca2+]i and MMP in PC12 cells following oxygen‐glucose deprivation‐reoxygenation injury. Cell Biology International. 36(11). 1043–1048. 13 indexed citations
16.
Liu, Lin, et al.. (2012). Beta-asarone attenuates ischemia–reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1. European Journal of Pharmacology. 680(1-3). 34–40. 54 indexed citations
17.
He, Yu‐Ping. (2009). Protective Effects of β-asarone on Cultured Neonatal Rat Myocardial Cells with Myocardial Ischemia-Reperfusion Injury. Guangzhou Zhongyiyao Daxue xuebao. 1 indexed citations
18.
He, Yu‐Ping. (2007). Effect of Ligustrazine on Cell Apoptosis and Expression of bcl-2 and p53 in Rats Hippocampal Neurons After Anoxia. Guangzhou Zhongyiyao Daxue xuebao. 1 indexed citations
19.
He, Yu‐Ping. (2006). Protective Effect of Combination of Effective Components in Acorus tatarinowii on PC12 Cell Injured by Beta Amyloid Protein. Traditional Chinese Drug Research and Clinical Pharmacology. 3 indexed citations
20.
He, Yu‐Ping. (2005). Protective Effects of Volatile Oil of Acorus tatarinowii Schott and β - Asarone on Cardiovascular System. Traditional Chinese Drug Research and Clinical Pharmacology. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026